AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2015
Sep 3, 2015
30016_dirs_2015-09-03_65bd3b25-fe22-43be-9904-1ef88f6aa841.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2015-09-01
Reporting Person: Claflin Bruce L. (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-09-01 | Deferred Stock Unit | $ | A | 503 | Acquired | Common Stock (503) | Direct | |
| 2015-09-01 | Non-Qualified Stock Option (Right to Buy) | $70.54 | A | 5629 | Acquired | 2025-08-31 | Common Stock (5629) | Direct |
Footnotes
F1: This equity grant represents pro rata equity compensation earned by the reporting person as a non-employee Director from his election to the IDEXX Laboratories, Inc. Board of Directors on 07/14/2015 until the Company's 2016 annual meeting of stockholders.
F2: Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest fully on 05/04/2016 and are payable as common stock one year following the Director's resignation from the Board of Directors.
F3: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vests fully on 05/04/2016.